Initial combination of linagliptin and metformin in patients with type 2 diabetes: efficacy and safety in a randomised, double-blind 1-year extension study

OBJECTIVE: To determine the efficacy and safety of linagliptin in initial combination with metformin in patients with type 2 diabetes. METHODS: This 1-year randomised, double-blind study was an extension of a 6-month randomised controlled trial, in which adults with type 2 diabetes received one of s...

Descripción completa

Detalles Bibliográficos
Autores principales: Haak, T, Meinicke, T, Jones, R, Weber, S, von Eynatten, M, Woerle, H-J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2013
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282285/
https://www.ncbi.nlm.nih.gov/pubmed/24118640
http://dx.doi.org/10.1111/ijcp.12308

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282285/
https://www.ncbi.nlm.nih.gov/pubmed/24118640
http://dx.doi.org/10.1111/ijcp.12308

Ejemplares similares